GGrantIndex
Sort

51,593 grants matching hepatitis

2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)

$406,250
Marina Serper · University Of Pennsylvania · R01 · FY2023 · AA

Modulating heterochromatin to improve beta cell differentiation from stem cells

$406,250
Kenneth S Zaret · University Of Pennsylvania · R01 · FY2022 · DK

B Cell Immunity to Hepatitis C Virus

$406,250
Steven Foung · Stanford University · R56 · FY2009 · AI

Modulating heterochromatin to improve beta cell differentiation from stem cells

$406,250
Kenneth S Zaret · University Of Pennsylvania · R01 · FY2021 · DK

Mechanisms underlying the genetic association between PPP1R3B and Alzheimer's Disease

$406,248
Daniel James Rader · University Of Pennsylvania · R01 · FY2021 · DK

Identification and characterization of cellular factors involved in HCV entry

$406,225
Charles M. Rice · Rockefeller University · R01 · FY2011 · AI

Regulation of Hepatic P450s by Anti-Cholesterol Drugs

$406,224
Thomas A Kocarek · Wayne State University · R01 · FY2020 · HL

Role of Forkhead Proteins in Insulin Action

$406,202
Domenico Accili · Columbia University Health Sciences · R01 · FY2013 · DK

The dynamics and mechanisms of autophagy in ethanol - induced liver pathogenesis

$406,148
Xiao-Ming Yin · Indiana University Indianapolis · R01 · FY2015 · AA

The dynamics and mechanisms of autophagy in ethanol - induced liver pathogenesis

$406,148
Xiao-Ming Yin · Indiana University Indianapolis · R01 · FY2014 · AA

Group testing for infectious disease detection: multiplex assays and back-end screening

$406,070
Christopher R Bilder · University Of Nebraska Lincoln · R01 · FY2016 · AI

ADOLESCENTS IN THE DRUG CULTURE AND STD TRANSMISSION

$406,002
Emory University · U01 · FY2001 · AI

Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.

$405,983
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2024 · DA

Acute pancreatitis and obesity

$405,971
Giamila Fantuzzi · University Of Illinois At Chicago · R01 · FY2010 · DK

Molecular Physiology of Biliary Lipid Secretion

$405,943
Brigham And Women'S Hospital · R01 · FY2005 · DK

The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation

$405,906
Zhong-Bin Deng · University Of Louisville · R01 · FY2023 · DK

Sleep Apnea and Dysregulation of Lipid Metabolism

$405,900
Vsevolod Y Polotsky · Johns Hopkins University · R01 · FY2012 · HL

Mechanisms of Immune Evasion by Hepatitis C Virus

$405,900
Andrea L Cox · Johns Hopkins University · R01 · FY2010 · AI

The impact of obesity-induced hepatic amyloid beta dysregulation on Alzheimer’s disease pathology

$405,849
Derick S Han · Keck Graduate Inst Of Applied Life Scis · R21 · FY2024 · AG

CARBOHYDRATE AND LIPID METABOLIC PATHWAYS

$405,846
Case Western Reserve University · R01 · FY2000 · DK

Beta Adrenergic Blockade and Insulin Sensitivity

$405,837
Robert R Wolfe · University Of Texas Med Br Galveston · P50 · FY2008 · GM

Evaulation of therapeutic benefits of HBV nucleocapsid assembly inhibitors

$405,835
Ju-Tao Guo · Drexel University · R01 · FY2014 · AI

Defining the molecular interactions within nanoparticles that enable delivery of long nucleic acids

$405,826
Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2025 · EB

Restoring awareness of hypoglycemia in type 1 diabetes

$405,815
Michael R Rickels · University Of Pennsylvania · U01 · FY2022 · DK

Pannexin 1 channels in diet-induced metabolic syndrome

$405,806
Norbert Leitinger · University Of Virginia · P01 · FY2023 · HL